Emergent Biosolutions Inc (EBS)
EBITDA Growth
-718.22%
Quarterly · Period ending:
EBS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-718.22%period ending
Latest reported-718.22%period ending
EBS Quarterly EBITDA YoY % (0.00% → -718.22%)
Year-over-year change
High-resolution chart · PNG
EBS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -718.2243% | |
| -63.9307% | |
| -157.6037% | |
| -2.2358% | |
| 116.3859% | |
| 106.5319% | |
| 272.2222% | |
| 303.2787% | |
| -367.0757% | |
| 162.4272% | |
| -132.6425% | |
| 295.2% | |
| 263% | |
| -372.4868% | |
| -88.9271% | |
| -1,036.3636% | |
| -161.2245% | |
| -69.8083% | |
| 21.2944% | |
| -100.9236% | |
| -68.3053% | |
| 627.907% | |
| 164.8848% | |
| 21.0366% | |
| 619.0698% | |
| 2,966.6667% | |
| 147.1864% | |
| 191.9881% | |
| -72.8535% | |
| -121.4286% | |
| -39.2176% | |
| -42.3646% | |
| 324.4373% | |
| -89.0093% | |
| 7.8802% | |
| 17.8566% | |
| 170.9059% | |
| -17.2777% | |
| -20.7332% | |
| -30.8254% | |
| -85.8519% | |
| 269.4191% | |
| 38.6979% | |
| 79.1925% | |
| 198.2967% | |
| 0.1812% | |
| 65.8278% | |
| 71.6148% | |
| -13.7413% | |
| -98.2258% | |
| 49.5723% | |
| 85.2864% | |
| 56.0495% | |
| 1.0661% | |
| -49.061% | |
| 224.4908% | |
| -46.0416% | |
| 72.0613% | |
| 30.4151% | |
| -82.3818% | |
| 47.9621% | |
| -784.7342% | |
| 535.788% | |
| 1,037.2925% | |
| -37.3732% | |
| -74.1863% | |
| 155.9225% | |
| -115.3149% | |
| 451.8889% | |
| 45.6884% | |
| -94.8826% | |
| 246.8566% | |
| 158.4076% | |
| 378.5884% | |
| -2.1412% | |
| -56.6386% | |
| -134.2765% | |
| -121.109% | |
| 216.3123% | |
| -64.7944% | |
| -24.231% | |
| -24.231% | |
| 21.5023% | |
| 38.7707% | |
| 38.7707% | |
| 38.7707% | |
| 0% |